Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Myriad gains gene testing rights in dispute with OncorMed
May 26 1998
More from Archive
More from Medtech Insight